A Study of the Plasmodium Falciparum Malaria Vaccine Candidate Pfs48/45 in Matrix-M Adjuvant in the UK

NCT05400746 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
TERMINATED
Status
17
Enrollment
OTHER
Sponsor class

Stopped Significant delays in vaccine adjuvant supply due to an out of specification within the context of the grant timeline. Limited safety and immunological data could be accrued from incomplete regimens.

Conditions

Interventions

Sponsor

University of Oxford